ATAZANAVIR\COBICISTAT: 210 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
210
Total FAERS Reports
12 (5.7%)
Deaths Reported
12
Hospitalizations
210
As Primary/Secondary Suspect
2
Life-Threatening
1
Disabilities
Active Ingredient: ATAZANAVIR SULFATE\COBICISTAT ·
First Report: 20100101 · Latest Report: 20250218
What Are the Most Common ATAZANAVIR\COBICISTAT Side Effects?
#1 Most Reported
Foetal exposure during pregnancy
34 reports (16.2%)
#2 Most Reported
Maternal exposure during pregnancy
31 reports (14.8%)
#3 Most Reported
Abortion spontaneous
16 reports (7.6%)
All ATAZANAVIR\COBICISTAT Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 34 | 16.2% | 3 | 0 |
| Maternal exposure during pregnancy | 31 | 14.8% | 0 | 0 |
| Abortion spontaneous | 16 | 7.6% | 0 | 0 |
| Hyperbilirubinaemia | 13 | 6.2% | 0 | 0 |
| Polyhydramnios | 13 | 6.2% | 0 | 0 |
| Drug interaction | 11 | 5.2% | 1 | 2 |
| Exposure during pregnancy | 11 | 5.2% | 0 | 0 |
| Spina bifida | 9 | 4.3% | 2 | 0 |
| Product use issue | 8 | 3.8% | 0 | 0 |
| Viral mutation identified | 8 | 3.8% | 0 | 0 |
| Death | 7 | 3.3% | 7 | 0 |
| Pathogen resistance | 7 | 3.3% | 0 | 1 |
| Placenta praevia | 7 | 3.3% | 0 | 0 |
| Abortion induced | 6 | 2.9% | 0 | 0 |
| Adverse event | 6 | 2.9% | 0 | 0 |
| Blood bilirubin increased | 6 | 2.9% | 0 | 0 |
| Nausea | 6 | 2.9% | 0 | 1 |
| Premature delivery | 6 | 2.9% | 0 | 0 |
| Creutzfeldt-jakob disease | 5 | 2.4% | 0 | 0 |
| Cushing's syndrome | 5 | 2.4% | 0 | 0 |
Who Reports ATAZANAVIR\COBICISTAT Side Effects? Age & Gender Data
Gender: 52.4% female, 47.6% male. Average age: 45.7 years. Most reports from: US. View detailed demographics →
Is ATAZANAVIR\COBICISTAT Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 1 | 0 | 0 |
| 2015 | 2 | 0 | 0 |
| 2016 | 5 | 1 | 1 |
| 2017 | 19 | 0 | 0 |
| 2018 | 20 | 0 | 0 |
| 2019 | 17 | 1 | 0 |
| 2020 | 17 | 0 | 2 |
| 2021 | 6 | 0 | 0 |
| 2022 | 1 | 0 | 1 |
| 2023 | 6 | 1 | 0 |
| 2024 | 1 | 1 | 0 |
| 2025 | 1 | 1 | 0 |
What Is ATAZANAVIR\COBICISTAT Used For?
| Indication | Reports |
|---|---|
| Hiv infection | 113 |
| Product used for unknown indication | 65 |
| Maternal exposure timing unspecified | 5 |
ATAZANAVIR\COBICISTAT vs Alternatives: Which Is Safer?
ATAZANAVIR\COBICISTAT vs ATAZANAVIR\RITONAVIR
ATAZANAVIR\COBICISTAT vs ATENOLOL
ATAZANAVIR\COBICISTAT vs ATENOLOL\CHLORTHALIDONE
ATAZANAVIR\COBICISTAT vs ATEZOLIZUMAB
ATAZANAVIR\COBICISTAT vs ATLANTIC SALMON OIL
ATAZANAVIR\COBICISTAT vs ATOGEPANT
ATAZANAVIR\COBICISTAT vs ATOMOXETINE
ATAZANAVIR\COBICISTAT vs ATOMOXETINE\ATOMOXETINE
ATAZANAVIR\COBICISTAT vs ATORVASTATIN
ATAZANAVIR\COBICISTAT vs ATORVASTATIN\EZETIMIBE
Official FDA Label for ATAZANAVIR\COBICISTAT
Official prescribing information from the FDA-approved drug label.